Andreas Hollenstein | Sr. Principal Scientist
F. Hoffmann-La Roche AG

Andreas holds an MS in Biochemistry/Molecular Biology and a PhD in (Radio) Oncology from ETH Zürich. He conducted his postdoctoral research in adoptive cell therapy at the Dutch Cancer Institute in Ton Schumacher's lab. Subsequently, he focused on antibody discovery and lead optimization at Genmab NL. Since 2020, Andreas has served as a scientist in immunosafety at the Roche Innovation Center Basel with a strong focus on preclinical immunogenicity risk assessment.